Amgen will lay off a small number employees from Dublin-headquartered Horizon Therapeutics next year, after closing its $27.8bn (€26.3bn) acquisition of the rare-disease drugmaker earlier this ...
The agency gave Akebia’s drug an OK after receiving more safety data, but imposed a strict boxed warning for its use that may limit uptake.
Two months after closing its multibillion-dollar acquisition of Mirati Therapeutics, Bristol Myers Squibb is bidding adieu to ...
Arrakis has also landed a collaboration with Swiss drug developer Roche, which provided a $190 million upfront payment, and another RNA-focused collaboration with Amgen Inc. (Nasdaq: AMGN), who ...
Amgen is arguably one of the most impressive companies in its industry. The pharma giant topped the analyst consensus for both revenue and non-GAAP EPS in Q4. Amgen's debt is rated investment ...
As with Epogen, the initial discoveries that laid the basis for the drug had ... That decade of investment and research was paying off. In 1992, Amgen hit the billion dollars sales mark and ...
At Argus Research, Jasper covers the Growth Pharmaceutical, Medical Technology, and Financial Technology companies. He received his undergraduate degree from Boston University, graduating cum ...
The FDA approved two of Sandoz’s biosimilars to denosumab, a bone drug developed by Amgen. Gritstone announced it will lay off 40% of its workforce. Sumitomo Pharma said it will lay off another 400 ...
Amgen still needs to show that the reduction in Lp(a) is accompanied by lower rates of cardiovascular outcomes, and will endeavour to show that in its phase 3 programme which will start to enrol a ...
The national debt is over $34 trillion, consumer credit card debt is a staggering $1.13 trillion, and many companies ...
ANNOUNCER: 'Think Tank' has been made possible by Amgen, arecipient of the Presidential ... you have the whole vision laid out justas it was in the 1960s. But the 1960s were a crucial point ...